hangzhou royall imp and exp co., ltd - China

Welcome to

hangzhou royall imp and exp co., ltd

Free Member

hangzhou royall imp and exp co., ltd
China

Home
Company Info
Contact Us
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Ms. liza yang

E-mail:

Send Message

Instant Messaging:

pollen03@gmail.com

Mobile Number:

Phone Number:

Address:

hangzhou, Zhejiang
China

Average User Review

There is no review for this company - Write a review

Registration Date:

Jun. 25, 2024

Last Updated:

Aug. 28, 2012

Business Nature:

Manufacturing, Trade of Chemicals category

Want to contact this company?

Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Jinlan Pharm-Drugs Technology Co., Limited ( with its export company Hangzhou Royal Import & Export Co., Ltd.) is located in Hangzhou, Zhejiang Province. Neighboring Ningbo port, Shanghai port, Hangzhou Xiaoshan Intâ € ™ l Airport and Shanghai Pudong Intâ € ™ l Airport, the transportation and production environment are excellent. JINLAN PHARMA is mainly engaged in R& D, manufacturing and marketing pharmaceuticals, chemical intermediates, Biochemicals, Veterinary medicines and Nutrition products.

With its strong ability in R& D, and world-leading process technology, JINLAN PHARMA develops the new and high-tech chemicals and pharmaceuticals. Synthesis capacity from gram scale, kg scale to mt scale is available.

JINLAN PHARMA focus on:
Veterinary products
Nutrition products
Agrochemicals
Active pharmaceutical Ingredients
Custom systhesis
Contract manufacturing

JINLAN PHARMA has high quality employee team, each department has special chemical technologists, and can offer special and latest chemical information as customer require. With our specialty, we have wide technological cooperation with Science Institutes and Organizations, which supply a strong technological support to the development of the company.

I am familiar with this company and want to review it.

You have [3] new inquiries.